Stockreport

NLS Pharmaceutics Successfully Appeals Nasdaq Delisting Notice

NLS Pharmaceutics Ltd. - Common Shares  (NLSP) 
PDF ZURICH, SWITZERLAND / ACCESSWIRE / November 14, 2022 / NLS Pharmaceutics Ltd. (Nasdaq: NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical co [Read more]